Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 1 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar pennysplants (99.58) Submitted: 11/22/2012 7:04:40 PM : Outperform Start Price: $53.10 ALXA Score: -99.29

Cleaning up after 2 year hiatus from CAPS.

Featured Broker Partners


Advertisement